What is the train‑of‑four (TOF) and how is it used to assess the depth of neuromuscular blockade?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Train-of-Four (TOF): Definition and Clinical Application

Train-of-four (TOF) is a nerve stimulation pattern that delivers four supramaximal electrical stimuli at 2 Hz over 2 seconds to assess neuromuscular blockade depth, with quantitative monitoring at the adductor pollicis muscle required to achieve a TOF ratio ≥0.9 before extubation to prevent residual paralysis and its associated morbidity and mortality. 1, 2

What is Train-of-Four?

TOF is a specific pattern of peripheral nerve stimulation used to monitor neuromuscular blockade. The technique involves:

  • Four consecutive electrical stimuli delivered at 2 Hz frequency (one stimulus every 0.5 seconds)
  • Applied to a peripheral nerve (typically the ulnar nerve)
  • Muscle response observed or measured at the corresponding muscle (adductor pollicis for ulnar nerve)
  • The ratio between the fourth and first response (T4/T1 ratio) quantifies the degree of blockade 1

How TOF Assesses Neuromuscular Blockade Depth

Quantitative vs Qualitative Monitoring

Quantitative monitoring is essential and must be used whenever neuromuscular blocking drugs are administered 2. The critical distinction:

  • Qualitative assessment (visual or tactile): Can only detect TOF ratios down to 0.4-0.6. Absence of fade does not exclude clinically significant residual blockade 3
  • Quantitative assessment (instrumental measurement): Provides numerical TOF ratio values, essential for detecting the "monitoring gap" between 0.4 and 0.9 2

Monitoring Site Selection

The adductor pollicis muscle via ulnar nerve stimulation is the recommended monitoring site 1. This muscle:

  • Has high sensitivity to neuromuscular blocking agents
  • Demonstrates slow recovery kinetics
  • More accurately reflects pharyngeal muscle recovery (the last muscles to recover) 3

Clinical Interpretation of TOF Responses

TOF Count (Number of Visible Twitches)

  • 0 twitches: Deep blockade - wait and maintain anesthesia 1
  • 1-2 twitches: Deep to moderate blockade
  • 3 twitches: Moderate blockade approaching reversal threshold
  • 4 twitches: Minimum threshold for neostigmine reversal (corresponds to TOF ratio ~0.2) 1

TOF Ratio (T4/T1)

  • <0.4: Significant residual blockade
  • 0.4-0.6: Moderate residual blockade (no visible fade, but clinically significant)
  • 0.7: Single twitch recovered to baseline, sustained tetanus 4
  • ≥0.9: Required threshold to eliminate residual neuromuscular blockade and allow safe extubation 1, 2

Critical Clinical Implications

Why TOF Ratio ≥0.9 Matters

Residual neuromuscular blockade (TOF ratio <0.9) directly increases morbidity and mortality 1:

  • Higher 24-hour postoperative mortality
  • Increased critical respiratory events in recovery (incidence 4-64% without proper monitoring) 2
  • Greater risk of postoperative pneumonia
  • Aspiration risk from pharyngeal muscle dysfunction
  • Delayed recovery room discharge
  • Risk of accidental awareness during general anesthesia 2

Common Pitfalls to Avoid

  1. Relying on clinical tests: Head-lift, hand grip, and tongue depressor tests have sensitivities of only 10-30% and cannot exclude residual blockade 2

  2. Using only qualitative monitoring: Peripheral nerve stimulators showing "no fade" may still have TOF ratios as low as 0.4, leaving patients at significant risk 3

  3. Assuming spontaneous breathing equals adequate recovery: Respiratory effort, coughing, and movement to command do not exclude clinically significant residual blockade 2

Practical Application for Reversal Decisions

Neostigmine Reversal Algorithm

Wait for 4 visible TOF responses before administering neostigmine 1:

  • If TOF count <4: Wait and maintain anesthesia, reassess later
  • If TOF count =4: Administer neostigmine 0.04 mg/kg with atropine 0.02 mg/kg
  • Expected efficacy: TOF ratio ≥0.9 in 10-20 minutes (faster with propofol vs sevoflurane maintenance) 1

Sugammadex Reversal Algorithm (Rocuronium Only)

Dose based on quantitative TOF assessment 1:

  • TOF ratio 0.5: 0.22 mg/kg (recovery <5 minutes)
  • 4 TOF responses: 1.0 mg/kg (recovery <5 minutes)
  • 2 TOF responses: 2.0 mg/kg (recovery <5 minutes)
  • Deep block (PTC 1-2): 4.0 mg/kg (recovery 3-5 minutes)
  • Very deep block/immediate reversal: 8.0 mg/kg (recovery 3-5 minutes)

Continue monitoring after sugammadex to detect potential recurarization 1

Essential Documentation

Document TOF ratio >0.9 before patient awakening and extubation 2. Every location where neuromuscular blocking drugs are used must be equipped with quantitative monitoring devices 2.

The evidence strongly supports that quantitative TOF monitoring is not optional but essential for patient safety, with direct impact on perioperative morbidity and mortality 1, 2.

Related Questions

What does the train-of-four (TOF) ratio represent in neuromuscular monitoring?
In a patient with hemiplegia undergoing general anesthesia, where should the train‑of‑four (TOF) monitor be placed and how should neuromuscular blockade be managed?
Is a quantitative or qualitative train of four (TOF) assessment best for monitoring neuromuscular blockade?
1. What is the major health problem resulting from a pulse deficit? (A) Bradycardia (B) Activity intolerance (C) Decreased cardiac output (D) Impaired tissue perfusion. 2. What should the nurse do when a pulse deficit is suspected? (A) Measure the radial pulse for one minute, then measure the apical pulse for one minute (B) Measure the radial pulse for 30 seconds, then measure the apical pulse for 30 seconds (C) Measure the radial pulse for one minute, wait five minutes, then measure the apical pulse for one minute (D) Ask another health‑care provider to count the radial pulse while the nurse counts the apical pulse. 3. After identifying a pulse deficit, which action should the nurse perform? (A) Reassess the apical‑radial pulse in five minutes (B) Assess the patient for signs of decreased cardiac output (C) Notify the primary health‑care provider of the pulse deficit (D) Initiate interventions directed toward managing the patient’s symptoms. 4. A patient has oral temperature 36.8 °C, radial pulse 112 weak and thready, apical pulse 117 regular, respirations 24 regular, blood pressure 104/56 right arm, 102/50 left arm; what is the pulse deficit? (A) 2 (B) 5 (C) 6 (D) 48. 5. Which of the following is an early manifestation of decreased cardiac output? (A) Fatigue (B) Substernal pain (C) Nail‑bed cyanosis (D) Shortness of breath.
How should a 2-year-old child presenting with a dry cough and wheezing be managed?
Should vitamin D3 (cholecalciferol) be taken with milk?
In type 2 diabetes, should repaglinide and gliclazide be co‑administered?
What is the recommended dosing regimen of aztreonam‑avibactam (aztreonam plus avibactam) for adults, including adjustments for renal impairment, and for pediatric patients?
Can mebendazole be safely administered to a 4-year-old child, and what is the appropriate dosage?
What are the natural reservoirs and sources of Enterobacter cloacae?
In a patient after return of spontaneous circulation from cardiac arrest, should vasopressin be used as the first-line vasopressor for post‑arrest hypotensive shock?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.